Log in to save to my catalogue

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012147

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

About this item

Full title

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

Publisher

New York: Elsevier Inc

Journal title

Laboratory investigation, 2011-01, Vol.91 (1), p.54-62

Language

English

Formats

Publication information

Publisher

New York: Elsevier Inc

More information

Scope and Contents

Contents

Sjögren's syndrome (SS) involves a chronic, progressive inflammation primarily of the salivary and lacrimal glands leading to decreased levels of saliva and tears that eventually result in dry mouth and dry eye diseases. TH17 cell populations secreting IL17A have been shown to have an important function in an increasing number of autoimmune disease...

Alternative Titles

Full title

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012147

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012147

Other Identifiers

ISSN

0023-6837,1530-0307

E-ISSN

1530-0307

DOI

10.1038/labinvest.2010.164

How to access this item